Doug Schenkel

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Doug Schenkel works at COWEN and is focused on Healthcare, ´╗┐Basic Materials sectors with 351 price targets and ratings documented since 2013 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 87.61% with an average time for price targets to be met of 180.86 days.

Most recent stock forecast was given on NVTA, Invitae Corporation at 09-Nov-2021.

Doug Schenkel best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA, INC).
The best stock recommendation documented was for GH (GUARDANT HEALTH, INC) at 10/29/2018. The price target of $40 was fulfilled within 4 days with a profit of $7.41 (22.74%) receiving and performance score of 56.84.

Average potential price target upside

Currently, out of the existing stock ratings of Doug Schenkel - 6405 which are a Hold (26.92%), 17225 which are a Buy (72.4%), 162 which are a Sell (0.68%)

AMRS DHR DXCM FLDM GH GNMK HOLX ILMN MYGN NVTA PACB TMO TNDM WAT ZY A EXAS NTRA QGEN NSTG AVTR PKI PODD

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

26

4 months 18 days ago

0/2 (0%)

$9.52 (61.13%)

Hold

4

$2.68 (203.03%)

2.5

6 months 8 days ago

2/3 (66.67%)

$-0.09 (1.37%)

19

Hold

2

$0.68 (51.52%)

15

7 months 17 days ago

2/5 (40%)

$7 (47.11%)

53

Buy

19

$17.2 (955.56%)

9

1 years 5 months 12 days ago

2/3 (66.67%)

$2.66 (39.45%)

16

Buy

20

$18.68 (1415.15%)

20

1 years 8 months 21 days ago

0/2 (0%)

$4.73 (31.27%)

Show more analysts
AMRS DHR DXCM FLDM GH GNMK HOLX ILMN MYGN NVTA PACB TMO TNDM WAT ZY A EXAS NTRA QGEN NSTG AVTR PKI PODD